Petrelintide
Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product Concentrations
Roche · Phase 1 · Completed · Enrollment 48
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Arm A | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm B | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm C | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm D | Obesity or overweight | n/r | n/r | n/r | n/r |